Watch Prof Sir Martin Landray’s panel at Milken Institute’s Future of Health Summit 2025.
Clinical research needs participants and yet researchers persistently struggle to engage them.
An unacceptable number of trials are delayed or fail to launch because of slow or low enrolment, which causes innovation to languish.
The cost to patients is vast. So, what can clinical researchers do about it?
This November, Protas CEO Prof Sir Martin Landray took to the stage at Milken Institute’s Future of Health Summit to explore how changing global policy and practice will enable community-based research.
Alongside a panel of experts and change-markers, Sir Martin explored themes including:
- The meaning of community in a clinical research setting
- How to reach typically underserved communities
- How to better design clinical trials to reach communities
- What needs to change in policy and practice
Sir Martin comments: “Anybody can design a trial that nobody can do and nobody can take part in… That’s exactly what people do so often over and over again.
“The key is to be really clear on the question and then cut out all the unnecessary stuff so that you make sure that the trial is operationally viable and really does answer that question.
“That includes for the community, the community of frontline healthcare workers and the community of patients who need their care.”
Watch the full panel:
Find out more about how Protas is working with Milken Institute.